The maker of an FDA-approved app says its algorithm can use images to assess surgery-related blood loss.
FDA is concerned state biosimilar legislation could make consumers uneasy about the category, J&J hands $75 million milestone payment for ibrutinib, Consumer Reports gets into drug apps
Patient use of the professional app prompted the latest iteration, and the foundation behind it is set to launch a media push.
The months-old app seeks to become an all-in-one HCP tool and work on a 3.0 version is already in place.
Plan B age limits retained and rejected, Celgene drugs gets expanded indication, Komen cuts back on walks, Apple is policing medical apps, OPDP director’s Q&A